Broadcom Inc. (AVGO)

Key Updates

AVGO has risen +2.12% since the October 1 report, recovering from $347.90 to the current $355.26. This move fully reverses the previous session's decline and brings the stock back to the level last seen on September 24. The catalyst appears to be a cluster of September 2–14 news items that have been digested by the market over the past month, including an earnings beat, reaffirmed AI revenue targets, and fresh analyst endorsements. The current price now sits just $0.01 below the September 22 local high of $355.27, suggesting the stock is testing a key resistance zone.

Current Trend

Year-to-date performance stands at +2.65%, reflecting a modest but positive trajectory. The six-month return of +12.94% indicates sustained upward momentum over the medium term, while the one-month decline of -3.26% highlights recent volatility. The stock has been oscillating between approximately $347.90 (September 24 and October 1 lows) and $355.27 (September 22 high) over the past two weeks, establishing a clear trading range. The current price of $355.26 is within 0.01% of the upper boundary of this range, and a decisive break above $355.27 would likely signal a continuation of the uptrend. Support is established at the $347.90 level, which has held on multiple tests.

Investment Thesis

The core investment thesis centers on Broadcom's position as a leading supplier of custom AI accelerators to major cloud and AI laboratory customers. The September 2 earnings report showed the company beating expectations, with AI labs doubling down on custom chips, validating the demand thesis. Management guided to "big numbers" for the coming quarters, though investors wanted more, creating a disconnect between company performance and market expectations. The CEO has explicitly stated that AI revenue targets haven't changed despite Anthropic's push to slow down, signaling confidence in the demand pipeline. The thesis remains intact but is being tested by high market expectations and concerns about guidance adequacy.

Thesis Status

The investment thesis remains constructive but is facing headwinds from elevated expectations. The earnings beat demonstrates operational strength, yet the stock fell after the report because weak guidance overshadowed the earnings beat, causing a 5% drop. This pattern — strong results, disappointing market reaction — has been a recurring theme, as noted in the Morningstar coverage of the stock's frustrating stretch for investors. The current price recovery to the top of the trading range suggests the market is gradually reassessing the guidance concerns. The thesis is intact but requires the company to deliver on its guidance in upcoming quarters to justify current valuations. Wall Street is lasering in on the company's forecast, indicating that forward guidance, not past performance, will drive the stock in the near term.

Key Drivers

• AI Custom Chip Demand: Broadcom's custom AI accelerator business is expanding as AI labs increase their orders, supporting revenue growth.
• Guidance Expectations: The company's forward guidance is the primary focus for investors, with Wall Street scrutinizing the forecast for signs of sustainable growth.
• Customer Announcements: The CEO's public reassurance that AI revenue targets remain unchanged addresses concerns about demand softening from key customers like Anthropic.
• Analyst Sentiment: New bullish endorsements, including from Macquarie Equity Research, are providing support despite the stock's recent underperformance.
• Strategic Partnerships: The company's work with Google on custom silicon continues to be a growth vector, as highlighted by analyst coverage.

Technical Analysis

AVGO is trading at $355.26, having recovered +2.12% since the October 1 report. The stock has established a clear trading range between $347.90 (support) and $355.27 (resistance) over the past two weeks. Today's price action brings the stock to the upper boundary of this range, within 0.01% of the September 22 high. A breakout above $355.27 would target the next resistance level, while a failure to break through could result in another test of the $347.90 support. The one-month decline of -3.26% versus the six-month gain of +12.94% indicates that the medium-term trend remains upward despite recent consolidation. The YTD gain of +2.65% shows the stock is essentially flat for the year, suggesting that much of the AI optimism has already been priced in.

Bull Case

• Earnings Beat Validates AI Demand: Broadcom beat expectations with AI labs doubling down on custom chips, confirming that the core growth driver is intact and expanding.
• Management Confidence in AI Targets: The CEO's statement that AI revenue targets haven't changed despite customer pushback signals strong visibility into the demand pipeline.
• New Analyst Endorsement: A new bullish analyst endorsement adds to the positive sentiment, potentially attracting new institutional buyers.
• Macquarie's Positive Outlook: Macquarie Equity Research specifically highlighted that this chipmaker can gain ground, citing its work with Google as a key growth driver.
• Strong Guidance Numbers: Despite investor disappointment, the company did guide to big numbers, indicating substantial growth ahead even if it fell short of the most aggressive estimates.

Bear Case

• Investor Disappointment with Guidance: The stock dropped 5% because weak guidance overshadowed the earnings beat, showing that market expectations exceed what the company is willing to commit to.
• Persistent Stock Underperformance: The stock has been in a frustrating stretch despite strong fundamentals, suggesting that sentiment remains negative and may take time to reverse.
• Forecast Scrutiny: Wall Street is lasering in on the company's forecast, creating elevated risk if future guidance disappoints again.
• Customer Concentration Risk: The need for the CEO to publicly address Anthropic's slowdown push highlights the vulnerability to individual customer decisions.
• Repeated Post-Earnings Declines: The pattern of the stock falling despite upbeat earnings suggests that the market is pricing in higher growth than the company can deliver, creating a persistent valuation overhang.